Search

SAVE THE DATE - Optos Peer Discussion Webinar

‘Working with ultra-widefield multi-modality retinal imaging: the clinical and practical value this technology adds to your ophthalmology clinic.’

London-based My i-Clinic offers cutting-edge CAIRS treatment for keratoconus

Revolutionary treatment paves the way for reducing cases of degenerative eye condition My i-Clinic is spearheading the treatment of keratoconus after adopting the innovative ‘CAIRS’ procedure to treat patients. Hailed as a game-changer by experts, the minimally invasive procedure is...

TowardPi Brings Next-Generation OCT/A to the UK

TowardPi, a fast-growing leader in ophthalmic imaging, has entered the UK market with its advanced swept-source OCT (SS-OCT) and OCT angiography (OCTA) systems. Distributed exclusively by Mainline Instruments, TowardPi is already well-established in Asia and is recognised for pioneering the...

Glaukos at ESCRS 2025

The 2026 ESCRS meeting in Copenhagen was a highly successful and busy event for Glaukos, highlighted by the launch of iStent infinite®. The new device was prominently featured across podium presentations, booth speaker sessions, and hands-on dry labs, following its...

Raphaél Ervinckx joins Glaukos

Glaukos Corporation has appointed Raphaél Ervinckx as Vice President and General Manager for the EMEAI region, marking a strategic move to support the company’s continued international growth. Raphaël Ervinckx brings extensive experience in the ophthalmology sector, most recently serving as...

Graham Popham joins Glaukos as Senior Director, Market Access EMEAI

Glaukos are delighted to announce the appointment of Graham Popham as Senior Director, Market Access EMEAI. Graham comments: "’m excited to join Glaukos at such a pivotal time in the evolution of ophthalmic care and growth of the organisation. Throughout...